San Diego, CA, United States of America

Carlos J Carrera

This inventor holds 9 USPTO granted patents. Top assignees: Scripps Research Institute, University of California, Other. Active years: 1992-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos J Carrera. Retrieved from https://idiyas.com/inventor/carlos-j-carrera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 222(Granted Patents)


Location History:

  • San Digeo, CA (US) (1994)
  • Trenton, NJ (US) (1999)
  • San Diego, CA (US) (1992 - 2003)

Company Filing History:


Years Active: 1992-2003

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations in Cancer Diagnosis and Treatment by Carlos J Carrera

Introduction

Carlos J Carrera is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of cancer research, holding a total of 9 patents. His work focuses on innovative methods for diagnosing and treating cancer, particularly through the understanding of genetic factors involved in tumor development.

Latest Patents

One of Carrera's latest patents is a method for early diagnosis of, and determination of prognosis in, cancer. This invention provides a method for diagnosing cancer associated with derangements of chromosome 9p21. The discovery underlying this invention is that such derangements originate from deletions occurring centromeric to STS 3.21. As cancer progresses, these deletions advance toward the gene encoding p16, allowing for early detection of tumor development.

Another significant patent by Carrera is a method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells. This in vivo method aims to deplete mammalian cells of adenosine 5′-monophosphate (AMP), which is useful in treating certain cancers. The method involves treating hosts with MTAse deficient tumors using an agent that inhibits adenylosuccinate synthetase, thereby depleting tumor cells of substrates necessary for AMP production.

Career Highlights

Throughout his career, Carlos J Carrera has worked with esteemed institutions such as the University of California and The Scripps Research Institute. His research has led to groundbreaking advancements in cancer diagnosis and treatment, showcasing his dedication to improving patient outcomes.

Collaborations

Some of Carrera's notable coworkers include Dennis A Carson and Howard B Cottam. Their collaborative efforts have contributed to the development of innovative solutions in cancer research.

Conclusion

Carlos J Carrera's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His innovative methods for diagnosis and treatment continue to pave the way for advancements in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…